retatrutide benefits clinical trial retatrutide FDA Approval Status 2026: Everything We Know So Far Retatrutide: A Promising Option for

Can these medications cause muscle loss

They work by mimicking natural hormones that slow digestion and help you feel full faster

Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists as they resemble a hormone called glucagon-like peptide 1, which stimulates insulin production, helps to lower blood sugar levels and, due to those metabolic effects, often results in weight loss

GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise